109384-27-2

Usage

Uses

Used in Pharmaceutical Industry:
1-METHYL-PIPERAZIN-2-ONE HYDROCHLORIDE is used as a chemical intermediate for the synthesis of various drugs, including antipsychotic, antihistaminic, and antimicrobial agents, due to its ability to facilitate the creation of these medicinal compounds.
Used in Dye Production:
1-METHYL-PIPERAZIN-2-ONE HYDROCHLORIDE is used as a component in the production of dyes, contributing to the coloration processes in various industries that require pigmentation.
Used in Herbicide Production:
1-METHYL-PIPERAZIN-2-ONE HYDROCHLORIDE is also utilized in the manufacturing of herbicides, where it plays a role in the development of substances that control, repel, or kill unwanted plants.
Used in Organic Compound Synthesis:
1-METHYL-PIPERAZIN-2-ONE HYDROCHLORIDE is used as a building block in the synthesis of other organic compounds, highlighting its versatility in chemical processes.

Upstream product

• 109384-26-1 1-tert-butoxycarbonyl-4-methyl-3-oxopiperazine 

Downstream Products

• 59702-07-7 1-methylpiperazin-2-one 
• 1464151-06-1 4-(6-(4-(4-methyl-3-oxopiperazine-1-carbonyl)phenyl)imidazo[1,2-b]pyridazin-3-yl)benzonitrile 
• 1560796-23-7 4-(4-bromophenyl)-1-methylpiperazin-2-one 
• 1446308-08-2 ethyl 2-(4-methyl-3-oxopiperazin-1-yl)-2-phenylacetate 
• 1446308-11-7 (3R)-3-(2-(4-methyl-3-oxopiperazin-1-yl)-2-phenylacetoxy)-1-(2-oxo-2-phenylethyl)-1-azoniabicyclo[2.2.2]octane chloride 
• 1446308-10-6 (R)-quinuclidin-3-yl 2-(4-methyl-3-oxopiperazin-1-yl)-2-phenylacetate 
• 1309652-58-1 4-{3-[4-amino-5-(2-phenyl-chroman-7-yl)-pyrrolo[2,3-d]pyrimidin-7-yl]-cyclobutylmethyl}-1-methyl-piperazin-2-one 
• 194350-88-4 4-methyl-3-oxopiperazin-1-ium monotrifluoroacetate 

Relevant academic research and scientific papers

PYRAZOLE DERIVATIVES

A compound represented by formula (I): (wherein Ar1 represents a phenyl group which may have 1 to 3 substituents, or a non-substituted 5- or 6-membered aromatic heterocyclic group; Ar2 represents (i) a non-substituted phenyl group, (ii) a phenyl group which has been substituted by a lower alkyl group having 1 to 3 groups or atoms selected from among a carbamoyl group, an amino group, a hydroxyl group, a lower alkoxy group, and a halogen atom, or (iii) a 5- or 6-membered nitrogen-containing aromatic heterocyclic group which has been substituted by 1 to 3 groups or atoms selected from among a lower alkyl group, a lower alkynyl group, a lower alkanoyl group, a carbamoyl group, a cyano group, an amino group, a hydroxyl group, a lower alkoxy group, and a halogen atom; and X represents a group represented by formula (II): (wherein the ring structure represents a 4- to 7-membered heterocyclic group which may have, in addition to the nitrogen atom shown in formula (II), one heteroatom selected from among nitrogen, oxygen, and sulfur, and which may be substituted by 1 to 4 groups or atoms selected from among a lower alkyl group, a carbamoyl group, an amino group, a hydroxyl group, a lower alkoxy group, an oxo group, a lower alkanoyl group, a lower alkylsulfonyl group, and a halogen atom)), a salt thereof, a solvate of the compound or the salt, and a drug.

PYRAZOLE DERIVATIVE

A compound represented by Formula (I): wherein Ar1 represents Formula (II): Ar2 represents a 5- or 6-membered aromatic heterocyclic group which may be substituted; and X represents Formula (III): a salt thereof, or a solvate of the compound or the salt. A potent platelet aggregation suppressant which does not inhibit COX-1 and COX-2 is provided.

1,5-DIHETEROCYCLE-1H-TRIAZOLE DERIVATIVE

The present invention relates to a compound represented by Formula (I): wherein Ar1, Ar2, R1 and R2 each represent a substituent, a salt thereof, or a solvate of the compound or the salt, and to a medicine containing the same. According to the present invention, a potent platelet aggregation suppressant which does not inhibit COX-1 and COX-2 is provided.

FIVE-MEMBERED HETEROCYCLIC DERIVATIVE

The present invention relates to a compound represented by formula (I): a salt of the compound, or a solvate of the compound or the salt; a drug containing any of the compounds, the salts, and the solvates; a preventive and/or therapeutic agent for an ischemic disease containing any of the compounds, the salts, and the solvates; and a platelet coagulation inhibitor containing any of the compounds, the salts, and the solvates. The compound of the present invention is useful as a strong platelet coagulation inhibitor without inhibiting COX-1 or COX-2.

Carbapenem derivatives

Carbapenem derivatives useful as antibacterial agents have the formula STR1 wherein: X represents a hydrogen atom or a methyl group; and Y represents a group of the formula: STR2 in which: Z represents an oxygen atom or two hydrogen atoms; R1 represents a hydrogen atom, a C1-4 alkyl group, a C1-4 alkanoyl group, or a C1-4 alkanesulfonyl group; R2 represents a hydrogen atom or a hydroxy group, and R3 represents a carbamoyl group; or R2 represents a carbamoyloxy group, and R3 represents a hydrogen atom or a carbamoyl group; R4 represents a hydrogen atom or a C1-4 alkyl group; and STR3 represents a 4-6 membered saturated heterocyclic group in which the indicated nitrogen atom is the only hetero-atom; or a pharmaceutically acceptable salt or ester thereof.